Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Unknown 10Completed 7Recruiting 4Withdrawn 3Not yet recruiting 2Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 24Stomach Neoplasms 5Rectal Neoplasms 5Neoplasm Metastasis 5Colonic Neoplasms 5Carcinoma, Hepatocellular 4Cholangiocarcinoma 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Unresectable Metastatic Colorectal Cancer 2Recurrence 2Neoplastic Cells, Circulating 2Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Ovarian Neoplasms 1Oligometastatic Gastric Adenocarcinoma 1Neoplasms, Second Primary 1Neoplasm, Residual 1Margins of Excision 1Lung Neoplasms 1Locally-advanced Rectal Cancer 1Locally Advanced Colorectal Carcinoma 1Hyperthermia 1Gastroesophageal Junction Adenocarcinoma 1Gastroesophageal Adenocarcinoma 1Gallbladder Neoplasms 1

Interventions

Bevacizumab 47lenvatinib 36atezolizumab 36durvalumab 28tremelimumab 23sintilimab 19Nivolumab 18pembrolizumab 14Radiosurgery 13tislelizumab 11Specimen Handling 10Ipilimumab 10camrelizumab 8apatinib 8Oxaliplatin 8Immune Checkpoint Inhibitors 8Fluorouracil 8Cyclophosphamide 8Blood Specimen Collection 8regorafenib 7cabozantinib 7fludarabine 6Sorafenib 6Radiotherapy 6Magnetic Resonance Spectroscopy 6Leucovorin 6donafenib 5Surgical Procedures, Operative 5Injections 5Immunoglobulin G 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Hepatocellular × Folfox protocol × Clear all
NCT07192185 2025-09-25

Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab

Sun Yat-sen University

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06893887 2025-07-02

ICT-HCC

Nanjing Tianyinshan Hospital

Phase NA Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05718492 2023-02-08

A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Sun Yat-sen University

Phase NA Recruiting
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05476432 2022-12-09

HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

Sun Yat-sen University

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡